COMPARATIVE STUDY ON THE EFFECTS OF HEMISCORPIUS LEPTURUS, HOTTENTOTTA SAULCYI AND MESOBUTHUS EUPEUS SCORPIONS ON BLOOD HEMOSTASIS IN RATS
|
|
- Elijah Harrington
- 5 years ago
- Views:
Transcription
1 Biochem. Cell. Arch. Vol. 11, No. 1, pp , 2011 ISSN COMPARATIVE STUDY ON THE EFFECTS OF HEMISCORPIUS LEPTURUS, HOTTENTOTTA SAULCYI AND MESOBUTHUS EUPEUS SCORPIONS ON BLOOD HEMOSTASIS IN RATS M. Razi Jalali 1, S. R. Fatemi 2 and T. Shirali 3 ¹Department of Clinical Sciences, Faculty of Veterinary Medicine, Shahid Chamran University of Ahvaz, Iran. ²Department of Basic Sciences, Faculty of Veterinary Medicine, Shahid Chamran University of Ahvaz, Iran. ³Graduated of Faculty of Veterinary Medicine, Shahid Chamran University of Ahvaz, Iran. jalali_m@scu.ac.ir, mrazijalali@yahoo.com (Accepted 15 February 2011) ABSTRACT Scorpion venom can induce significant alterations in blood parameters. Several publications have reported on the effects of scorpion envenomation on blood coagulation. The aim of this research was to compare the effects of H. lepturus, M. eupeus and H. saulcyi scorpion venoms on blood coagulation system in rats. For this aim 96 Wistar rats were divided randomly into 4 equal groups (A, B, C and D). Group A, received normal saline intraperitonealy as control group. Group B, C and D received H. lepturus (3mg/kg), M. eupeus (1.5mg/kg) and H. saulcyi (1mg/kg) venom ip, respectively. Blood samples were taken by heart puncture with sodium citrate 3.6%, at 1, 3, 24 and 48 hours after envenomation. Samples were used for evaluation of Prothrombin time (PT), Activated partial thromboplastin time (APTT), fibrinogen level and platelet count. Statistical analysis was done by SPSS_ 16, Anova test for evaluation of the data. Results showed that PT and APTT in different times after envenomatin were increased significantly in groups B and C compare to control group. The maximum alterations in these tests were seen at 3 hours after envenomatin in both groups. Plasma fibrinogen also was increased in group B and C at 1 and 3 hours after envenomatin. After 24 and 48 hours plasma fibrinogen was gradually reduced to the level of control group. On the other hand the plasma fibrinogen significantly increased after envenomation with H. saulcyi at different times. Platelet count was decreased significantly at 3 and 24 hours after envenomatin in groups B and C. However, Platelet count was increased gradually. Based on the results of this study it seems that the effects of H. lepturus and M. eupeus on blood hemostasis were similar to each other. In addition it seems that H. saulcyi has no significant effects on blood hemostasis and the diagnosis of the effective mechanism on hemostatic system needs more research. Key words : Scorpion, venom, coagulation test, rat. INTRODUCTION Scorpion sting is an acute life-threatening, time-limiting medical emergency more commonly seen in villagers. Among the different species of scorpions in Iran, Hemiscorpius lepturus, Mesobuthus eupeus and Hottentota saulcyi are of medical importance. Investigations showed that following these scorpion sting, victims have presented severe pain, hyperemia, edema, thirst, dry mouth, hypotension, nausea, hypertension, elevated bronchial secretion, difficulty in breathing, tachycardia and cyanosis (Ozkan et al, 2008). Changes in blood coagulation profiles and presence of acute disseminated intravascular coagulation (DIC) were observed in animals and man after scorpion venom injection (Murthy et al, 1988). Direct effect of toxins on neurons could contribute to seizures and encephalopathy in some children. However, hemiplegia and other neurological lesions have been attributed to fibrin deposition resulting from DIC. These were confirmed in autopsy studies of human scorpion sting victims. Acute rise in blood pressure due to sympathetic stimulation, rupture of un-protected perforating arteries, intracerebral hemorrhage and cerebral infarction due to DIC are possibly related to CNS manifestations. Some species of scorpion (Tityus discrepans) cause abundant micro thrombi in rabbit lungs. It is suggested that these clotting alterations are fundamental to produce acute lung injury and increased alveolocapillary membrane permeability (D Suze et al, 1999). Venom MATERIALS AND METHODS Hemiscorpius lepturus, Hottentotta saulcyi and Mesobuthus eupeus venom were obtained by electric shock at the scorpion telson in the department of venomous animals, Razi Vaccine and Serum Research Institute of Ahvaz. It was lyophilized and stored at 4 C until use. Experimental protocol Ninety six Wistar rats with an average weight of 200g were used in this study. All animals were housed under
2 126 Razi Jalali et al conditions of controlled light (12-hour-light 12-hour-dark cycle), temperature (24 ± 1 C) and humidity (55 ± 5%), with standard diet and water available ad libitum. All animals were kept in compliance based on the Guide for Care and Use of Laboratory Animals. Rats were divided randomly into 4 equal groups as below: Group A: Received normal saline intraperitonealy as control group. Group B: Received Hemiscorpius lepturus scorpion venom (3mg/kg) Intraperitonealy. Group C: Received Mesobothus eupeus scorpion venom (1.5mg/kg) Intraperitonealy. Group D: Received Hottentota saulcyi scorpion venom (1mg/kg) Intraperitonealy. Blood samples were taken by heart puncture with sodium citrate 3.6%, at 1, 3, 24 and 48 hours after envenomation. Plasmas were used for evaluation of Prothrombin Time (PT), Activated Partial Thromboplastin Time (APTT), fibrinogen level and platelet count. Prothrombin time Prothrombin time was assessed on citrated plasma by means of a standard kit. The PT kit was based on the assay principle that the addition of an adequately calcified amount of tissue factor (factor III) to citrated plasma activates factor VII, which induced the formation of a stable plug. The assay procedure was performed by placing 200 µl of tissue factor (PT reagent) in a test tube preheated to 37 C and subsequently adding 100 µl of citrated plasma. Upon the addition of test plasma, a stopwatch was started, and the clotting time was measured. The time in seconds from plasma-reagent mixing to visual clot formation was defined as the PT Activated partial thromboplastin Activated partial thromboplastin time was determined from citrated plasma by means of a standard kit. The APTT kit was based on the addition of a platelet substitute (phospholipids and ellagic acid as a soluble activator) and calcium chloride, which induced the formation of a stable plug. The assay procedure was performed by placing 100 µl of citrated plasma and 100 µl of APTT reagent (preheated to 37 C) in a test tube preheated to 37 C, followed by an additional incubation for 3 min at 37 C, and then adding 100 µl of calcium chloride that had been preheated to 37 C. Upon the addition of calcium chloride, a stopwatch was started and the clotting time was measured. The time in seconds from calcium chloride addition to visual clot formation was defined as the APTT Fibrinogen determination Fibrinogen determination was performed using citrated plasma by means of a standard kit. The standard kit for the quantitative determination of fibrinogen was based on the addition of a relatively large amount of thrombin to diluted citrated plasma, ensuring that the clotting time depended on only the fibrinogen contained in the sample. The assay procedure consisted of placing 200 µl of diluted plasma (diluted 1:10 by the combination of 100 µl of plasma µl of buffer) in a test tube preheated to 37 C, incubating for an additional 2 min at 37 C, and then adding 100 µl of the fibrinogen reagent. Upon the addition of fibrinogen reagent, a stopwatch was started, and the clotting time was measured. The time (seconds) until clot formation was automatically converted into mg/dl by the automated mechanical endpoint coagulation instrument RESULTS AND DISCUSSION Animal venoms are known for causing coagulopathy disorders (Brazon et al, 2008; Han et al, 2008; Marino et al, 2009; Oliveira-Carvalho et al, 2008; Valdez- Cruz et al, 2004). The best anticoagulants or hemorrhagic components studied are those from venomous snakes (Kini 2005; Kini and Evans, 1987). Several of these specific components are well characterized and grouped into families of proteins such as proteinases and metalloproteinases, C-type lectins, desintegrins and phospholipases. They usually affect: procoagulation, fibrinogen clotting, fibrinolysis, platelet-activation, anticoagulation, and might cause thrombotic or haemorrhagic manifestations (Kini and Evans, 1989). Some scorpion venoms also cause coagulopathy; however the number and type of components thus far characterized is small. There are reports indicating that the venom from the scorpions Hottentotta judaicus, Heterometrus spinnifer, Parabuthus transvaalicus, Androctonus australis, Scorpio maurus palmatus, Leiurus quinquestriatus habraeus and Pandinus imperator species, delay the clotting time of plasma. In particular the venom of P. imperator and P. transvaalicus venoms delay the clotting time by 2.5 and 2.3 fold respectively; whereas the other venoms delay the clotting around times (Tan and Ponnudurai, 1992). Venom from P. imperator and P. transvaalicus compared with snake venoms are 3 4 times less anticoagulant. The venom from the scorpion Buthus tamulus, in general causes coagulopathy, and it has been shown to cause disseminated intravascular coagulopathy
3 Effects of scorpion on blood of rats 127 Table1 : Changes of Mean± SE of coagulation test in different times in control group. Table 2 : Changes of Mean± SE of coagulation test in different times in group B (Hemiscorpius lepturus). PT ( sec) 10.6± ± ± ±2.1 APTT( sec) 29.7± ± ± ±3.1 Fibrinogen mg/dl 316±23 321±21 311±29 321±22 Platelet k/ul 222±23 228±24 236±27 234±34 Table3 : Changes of Mean± SE of coagulation test in different times in group C. (Mesobothus eupeus). PT ( sec) 15.1± ± ± ±2.2 bcd acd ab ab APTT( sec) 39.4± ± ± ±3.8 Fibrinogen 397±21 326± ± ±3.8 mg/dl bcd acd ab ab Platelet k/ul 201±14 175±12 152±19 191±18 PT( sec) 16.1± ± ± ±2.7 bc ad ad bc APTT( sec) 37.4± ± ± ±4.5 bcd acd abd abc Fibrinogen 321± ±31 307±16 315±18 mg/dl b acd b b Platelet k/ul 217±19 187±14 199±19 221±16 bc ad ad bc Table 4 : Changes of Mean± SE of coagulation test in different times in group D (Hottentota saulcyi) PT ( sec) 11.7± ± ± ±2.4 APTT( sec) 3.4± ± ± ±3.6 Fibrinogen 324±21 385±31 362±26 341±32 mg/dl bcdbcd acd abd abc Platelet k/ul 224±21 227±24 216±19 229±18 (DIC), (Radhakrishna Murthy et al, 1988). Injection of this scorpion venom intravenously (i.v.) at sub lethal dose into dogs and rabbits causes alteration in the coagulation mechanism (Gajalakshmi, 1982). Human accidents due to sting by the scorpion Palamneus gravimanus activates coagulation, probably mediated by a venom component acting on Factor X; it also has an inhibitory effect over thrombin (Hamilton et al, 1974). It has been demonstrated that high concentration of T. discrepans venom in human plasma fraction, increases the severity of the envenoming symptoms, by modification of the partial thromboplastin time (PTT) and prothrombin time (PT), rising the cytokines levels and increasing amylasemia and glycemia (D Suze et al, 2003). Brazon et al (2008) reported separation of T. discrepans venom into six sub-fractions by gel filtration on Protein-Pack 125 and assayed the effects on PTT and PT. Fraction 1 contains high molecular weight proteins, which decreases the PTT time in a dose dependent manner. Fractions 2 and 6 contain peptides that prolong the PTT and PT time. The latter are probably peptides like serpin that inhibit serine-protease activities. Results of this study showed that PT and APTT in different times after envenomatin were increased significantly in groups B (H. lepturus) and C (M. eupeus) compare to control group. The maximum alterations in these tests were seen at 3 hours after envenomation in both groups. Plasma fibrinogen also was increased in group B and C at 1 and 3 hours after envenomatin. After 24 and 48 hours plasma fibrinogen was gradually reduced to the level of control group. On the other hand the plasma fibrinogen significantly increased after envenomation with H. saulcyi at different times. Platelet count was decreased significantly at 3 and 24 hours after envenomatin in groups B and C. However, Platelet count was increased gradually. Patel et al (1992) showed that blood clotting time was significantly increased by venom injection (0.5 mg/ kg, IV) in rabbits at 0.5 and 6 hours interval (P < 0.05). This increase in blood clotting time was not significant at the interval of 24 and 48 hrs. Increased blood clotting time and hemorrhages observed in this study are correlated with the published observations that venom has anticoagulant property, which may possibly be due to calcium lack. It has been suggested that the venom is likely to produce chelation with ionic calcium and to
4 128 Razi Jalali et al change capillary permeability (Ismail et al, 1973). In other study on the effects of different doses of scorpion (Odontobuthus doriae) venom on hematological values in dog showed that Sedimentation rate, coagulation time, bleeding time and partial thromboplastin time significantly increased. Neutrophilic leukocytosis in addition to eosinopenia, thrombocytopenia and monocytopenia were also observed (p<0.05). Results indicate that hematological changes in the dogs led to a reactional leukocytosis and coagulopathies. The effect of toxin on liver led to coagulation. This suggests the probability of the existence of hepatotoxic factor(s) in the venom of this type of scorpion (Shorijeh et al, 2003). Kochar et al (2002) reported a case of scorpion sting that presented with right hemiparesis and deranged level of consciousness. Prolonged bleeding time and clotting time, decreased platelet counts, prolongation of PT and APTT with positive fibrinogen degradation products (FDP) D-dimer and CT scan findings of multiple cerebral hemorrhagic infacts indicating the presence of disseminated intravascular coagulation (DIC) as a cause of hemiparesis. Patient was managed with fresh blood transfusion and conventional treatment with favorable outcome. Disseminated intravascular coagulation occurred in dogs given scorpion venom subcutaneously in doses of 3 mg/kg (Bothotus tumulus) body weight. Treatment with heparin reversed the coagulation abnormality of the syndrome and 10 out of 12 dogs survived. Necropsy findings in human patients stung by scorpions suggest that this syndrome also occurs in man (Sita devi et al, 1970). In other study venom from the scorpion (Heterometrus fulvipes) was injected in sublethal doses and haematological studies were observed before and after venom administration. Distrubances in coagulation was not significant, but they may account for the cardiovascular changes frequently seen in scorpion envenomation. Present study clearly reveals that the coagulation abnormalities are not responsible for other clinical changes like myocardial infractions, cardiovascular changes of scorpion sting (Vanja et al, 1996). Emam et al (2008) in evaluation the effects of H. lepturus scorpion venom on hematological changes showed that quick diagnosis and treatment of scorpion stinging is very important factor for decreasing the mortality in sorpion envenomation. According to the results of this research and compare to other studies, it has been shown that hemostatic system can be affected by scorpion venom as a target organ. Based on the results of this study it seems that the effects of H. lepturus and M. eupeus on blood hemostasis were similar to each other. In addition it seems that H. saulcyi has no significant effects on blood hemostasis and the diagnosis of the effective mechanism on hemostatic system needs more research. REFRENSES Brazon J, Guerrero B, Arocha-Piñango C L, Sevcik C and D Suze G (2008) Effect of Tityus discrepans scorpion venom on global coagulation test. Preliminary studies. The J. Clinical Investig. 49, Casella S, Giannetto C, Fazio F, Giudice E and Piccione G (2009) Assessment of prothrombin time activated partial thromboplastin time, and fibrinogen concentration on equine plasma samples following different storage conditions. J. Veterinary Diagnostic Investig. 21, Devi C S, Reddy N C, Lakshmidevi S, Subramaniyam Y R and Reddy C R R M (1970) Defibrination syndrome due to scorpion venom poisoning. British Medical J. 1, D Suze G, Moncada S, Gonzalez C, Sevcik C, Aguilar V and Alagon A (2003) Relationship between plasmatic levels of various cytokines, tumour necrosis factor, enzymes, glucose and venom concentration following Tityus scorpion sting. Toxicon 41, D Suze G, Diaz P, Salazar V, Sevcik C and Brazon J (2007) Effect of leukocyte inhibitors benzydamine and cyclophosphamide, on lung injury caused by Tityus discrepans scorpion venom. Toxicon 50, Emam S J, Khosravi A D and Alemohammad A (2008) Evaluation of hematological and urine parameters in hemiscorpius lepturus (Gadim) victims referred to razi hospital, Ahwaz, Iran. J.. Medical Sciences 8, Gajalakshmi B E (1982) Coagulant studies following scorpion venom injection in animals. Indian J.Medical Res. 76, Hamilton P L, Ogston D and Douglas A (1974) Coagulant activity of the scorpion venoms Palamneus gravimanus and Leiurus guinquestriatus. Toxicon 12, Han T S, Teichert R W, Olivera B M and Bulaj G (2008) Conus venoms a rich source of peptidebased therapeutics. Current Pharmaceutical Design J. 14, Ismail M, Osman O H and El-Asmar M F (1973) Pharmacological studies of the venom from the scorpion Buthus minax (L. Koch). Toxicon 11, Jafari Shoorijeh S and Raffe M (2003) Efficacy of different doses of scorpion (Odontobuthus) venom on hematological values in the dog. Iranian J. Veterinary Research 1, Kini R M and Evans H J (1987) Structure-function relationships of phospholipases. The anticoagulant region of phospholipase A2. J. biol. Chem. 262, Kini R M and Evans H J (1989) A model to explain the pharmacological effects of snake venom phospholipases A2. Toxicon 27, Kini R M (2005) Structure-function relationships and mechanism of anticoagulant phospholipase A2 enzymes from snake venoms. Toxicon 45, Kochar D K, Singh P, Sharma B V, Saini G, Aggarwal P and Gauri L A (2002) Scorpion envenomation causing hemiparesis. J.
5 Effects of scorpion on blood of rats 129 Association Physicians of India 50, Marino A, Morabito R and La Spada G (2009) Factors altering the haemolytic power of crude venom from Aiptasia mutabilis (Anthozoa) nematocysts. Comp. Biochem.Physiol. Part A: Molecular & Integrative Physiol. 152, Murthy R K, Zolphaghrian H, Medh J D, Kudalkar J A, Yeolekar M E, Pandit S P, Khopkar M, Dave K N and Billimoria F R(1988) Disseminated intravascular coagulation and disturbances in carbohydrate and fat metabolism in acute myocarditis produced by scorpion (Buthus tamulus) venom. Indian J.Medical Res. 87, Oliveira-Carvalho A L, Guimarães P R, Abreu P A, Dutra DL, Junqueira-de-Azevedo I L, Rodrigues C R, Ho P L, Castro H C and Zingali R B (2008) Identification and characterization of a new member of snake venom thrombin inhibitors from Bothrops insularis using a proteomic approach. Toxicon 51, Ozkan O, Bakir F and Adiguzel S (2008) Effects of Androctonus crassicauda (Olivier, 1807) (scorpiones: Buthidae) venom on rat metabolism. J. Venomous Animals and Toxins including Tropical Diseases 14, Patel B, Bhatt M I and Dave K C (1992) Toxic effects of scorpion venom (Buthus tamulus) in rabbits and guinea pigs. Indian J.Pharmacol. 24, Tan N H and Ponnudurai G (1992) Comparative study of the enzymatic, hemorrhagic, procoagulant and anticoagulant activities of some animal venom. Comp. Biochem. Physiol. 103, Valdez-Cruz N A, Batista C V, Zamudio F Z, Bosmans F, Tytgat J and Possani L D (2004) Phaiodotoxin, a novel structural class of insect-toxin isolated from the venom of the Mexican scorpion Anuroctonus phaiodactylus. Eur. J.Biochem.271, Vanaja G (1996) Haematological observation following Heterometrus fulvipes venom administration in rat. Indian J. Hematol. Blood Transf. 14,
BIOCHEMICAL CHANGES AND MANIFESTATIONS OF ENVENOMATION PRODUCED BY Odonthobuthus doriae VENOM IN RABBITS
Received: March 15, 2005 Accepted: June 15, 2005 Published online: February 24, 2006 J. Venom. Anim. Toxins incl. Trop. Dis. V.12, n.1, p.67-77, 2006. Original paper - ISSN 1678-9199. BIOCHEMICAL CHANGES
More informationInhibition of Nephrotoxic Activity of Mesobuthus Eupeus Scorpion Venom by Commercial Polyvalent Antivenom in Rabbits
Iranian Journal of Toxicology Volume 8, No 27, Winter 2015 Inhibition of Nephrotoxic Activity of Mesobuthus Eupeus Scorpion Venom by Commercial Polyvalent Antivenom in Rabbits Ehsan Zayerzadeh*1 Received:
More informationBLEEDING DISORDERS Simple complement:
BLEEDING DISORDERS Simple complement: 1. Select the statement that describe the thrombocytopenia definition: A. Marked decrease of the Von Willebrandt factor B. Absence of antihemophilic factor A C. Disorder
More informationEDUCATIONAL COMMENTARY DISSEMINATED INTRAVASCULAR COAGULATION
EDUCATIONAL COMMENTARY DISSEMINATED INTRAVASCULAR COAGULATION Educational commentary is provided through our affiliation with the American Society for Clinical Pathology (ASCP). To obtain FREE CME/CMLE
More informationDisseminated Intravascular Coagulation. M.Bahmanpour MD Assistant professor IUMS
به نام خدا Disseminated Intravascular Coagulation M.Bahmanpour MD Assistant professor IUMS Algorithm for Diagnosis of DIC DIC Score factor score Presence of known underlying disorder No= 0 yes=2 Coagolation
More informationInstruments smart solutions & service IGZ Instruments AG Räffelstrasse 32 CH 8045 Zürich
ADP (Adenosine-5 -Diphosphate) 101312 3 x 0.5mL ADP is a lyophilized preparation of adenosine-5 -diphosphate. The working concentration of the reconstituted reagent is 2 x 10-4 M. ADP is for use in routine
More informationL iter diagnostico di laboratorio nelle coagulopatie congenite emorragiche
L iter diagnostico di laboratorio nelle coagulopatie congenite emorragiche Armando Tripodi Angelo Bianchi Bonomi Hemophilia and Thrombosis Center Dept. of Clinical Sciences and Community Health University
More informationMASSIVE TRANSFUSION DR.K.HITESH KUMAR FINAL YEAR PG DEPT. OF TRANSFUSION MEDICINE
MASSIVE TRANSFUSION DR.K.HITESH KUMAR FINAL YEAR PG DEPT. OF TRANSFUSION MEDICINE CONTENTS Definition Indications Transfusion trigger Massive transfusion protocol Complications DEFINITION Massive transfusion:
More informationDisseminated intravascular coagulation (DIC) Dr. Klara Vezendi Szeged University Transfusiology Department
Disseminated intravascular coagulation (DIC) Dr. Klara Vezendi Szeged University Transfusiology Department Disseminated intravascular coagulation (DIC, consumptive coagulopathy) is a clinicopathologic
More informationHEME 10 Bleeding Disorders
HEME 10 Bleeding Disorders When injury occurs, three mechanisms occur Blood vessels Primary hemostasis Secondary hemostasis Diseases of the blood vessels Platelet disorders Thrombocytopenia Functional
More informationFirst report of death due to Hemiscorpius acanthocercus envenomation in Iran: Case report
Electronic Physician (ISSN: 2008-5842) September 2015, Volume: 7, Issue: 5, Pages: 1234-1238, DOI: 10.14661/1234 First report of death due to Hemiscorpius acanthocercus envenomation in Iran: Case report
More informationTwo Biological Active Fractions Isolated from Buthotus schach (BS) Scorpion Venom Examined on Striated Muscle Preparation, In-vitro
Iranian Journal of Pharmaceutical Research (212), 11 (3): 95-911 Received: November 21 Accepted: May 212 Copyright 212 by School of Pharmacy Shaheed Beheshti University of Medical Sciences and Health Services
More informationOPTIMIZATION OF ANTISCORPION VENOM PRODUCTION OZKAN O. (1), ADIGÜZEL S. (1), ATES C. (1), BOZYIGIT I. (1), FILAZI A. (2)
Received: June 14, 2005 Accepted: October 18, 2005 Abstract published online: January 20, 2006 Full paper published online: August 31, 2006 J. Venom. Anim. Toxins incl. Trop. Dis. V.12, n.3, p.390-399,
More informationApproach to disseminated intravascular coagulation
Approach to disseminated intravascular coagulation Khaire Ananta Shankarrao 1, Anil Burley 2, Deshmukh 3 1.MD Scholar, [kayachikitsa] 2.Professor,MD kayachikitsa. 3.Professor and HOD,Kayachikitsa. CSMSS
More informationJohn Davidson Consultant in Intensive Care Medicine Freeman Hospital, Newcastle upon Tyne
John Davidson Consultant in Intensive Care Medicine Freeman Hospital, Newcastle upon Tyne Overview of coagulation Testing coagulation Coagulopathy in ICU Incidence Causes Evaluation Management Coagulation
More informationProthrombin Complex Concentrate- Octaplex. Octaplex
Prothrombin Complex Concentrate- Concentrated Factors Prothrombin Complex Concentrate (PCC) 3- factor (factor II, IX, X) 4-factor (factors II, VII, IX, X) Activated 4-factor (factors II, VIIa, IX, X) Coagulation
More informationSymptom patterns in adult patients stung by scorpions with emphasis on coagulopathy and hemoglubinuria
The Journal of Venomous Animals and Toxins including Tropical Diseases ISSN 1678-9199 2012 volume 18 issue 4 pages 427-431 Short Communication Symptom patterns in adult patients stung by scorpions with
More informationThrombolysis administration
Thrombolysis administration Liz Mackey Stroke Nurse Practitioner Western Health Sunshine & Footscray Hospital, Melbourne Thanks ASNEN committee members Skye Coote, Acute Stroke Nurse, Eastern Health (slide
More informationRecombinant Factor VIIa for Intracerebral Hemorrhage
Recombinant Factor VIIa for Intracerebral Hemorrhage January 24, 2006 Justin Lee Pharmacy Resident University Health Network Outline 1. Introduction to patient case 2. Overview of intracerebral hemorrhage
More informationDisseminated Intravascular Coagulation (DIC) Seminar. Ron Kopilov 4 th year Medical Student, Tel Aviv University Internal Medicine A 8.3.
Disseminated Intravascular Coagulation (DIC) Seminar Ron Kopilov 4 th year Medical Student, Tel Aviv University Internal Medicine A 8.3.2012 1 Our plan: Understand the pathophysiology Identify risk factors
More informationBehzad Poopak, DCLS PhD
Behzad Poopak, DCLS PhD Test Report Name Age Critical Low HEMATOLOGY Activated Partial Thromboplastin Time, Plasma Critical High - 150 sec Units Fibrinogen 60 - mg/dl INR (International Normalizing
More informationCoagulation Disorders. Dr. Muhammad Shamim Assistant Professor, BMU
Coagulation Disorders Dr. Muhammad Shamim Assistant Professor, BMU 1 Introduction Local Vs. General Hematoma & Joint bleed Coagulation Skin/Mucosal Petechiae & Purpura PLT wound / surgical bleeding Immediate
More informationUNIT VI. Chapter 37: Platelets Hemostasis and Blood Coagulation Presented by Dr. Diksha Yadav. Copyright 2011 by Saunders, an imprint of Elsevier Inc.
UNIT VI Chapter 37: Platelets Hemostasis and Blood Coagulation Presented by Dr. Diksha Yadav Hemostasis: Prevention of Blood Loss Vascular constriction Formation of a platelet plug Formation of a blood
More informationCOAGULATION PROFILE AND ANALYSIS OF OUTCOME OF BLOOD COMPONENT THERAPY IN SNAKE BITE VICTIMS
COAGULATION PROFILE AND ANALYSIS OF OUTCOME OF BLOOD COMPONENT THERAPY IN SNAKE BITE VICTIMS Dr Aboobacker Mohamed Rafi 1, Dr Susheela J Innah Senior Resident Department of Transfusion Medicine Jubilee
More informationDISSEMINATED INTRAVASCULAR COAGULATION (DIC) Pichika Chantrathammachart MD Division of Hematology, Department of Medicine Ramathibodi Hospital
DISSEMINATED INTRAVASCULAR COAGULATION (DIC) Pichika Chantrathammachart MD Division of Hematology, Department of Medicine Ramathibodi Hospital Disseminated intravascular coagulation (DIC) Disseminated
More informationHaemostasis & Coagulation disorders Objectives:
Haematology Lec. 1 د.ميسم مؤيد علوش Haemostasis & Coagulation disorders Objectives: - Define haemostasis and what are the major components involved in haemostasis? - How to assess the coagulation status?
More informationEMSS17: Bleeding patients course material
EMSS17: Bleeding patients course material Introduction During the bleeding patients workshop at the Emergency Medicine Summer School 2017 (EMSS17) you will learn how to assess and treat bleeding patients
More informationGuidelines for the management of warfarin reversal in adults
SharePoint Location Clinical Policies and Guidelines SharePoint Index Directory General Policies and Guidelines Sub Area Haematology and Transfusion Key words (for search purposes) Warfarin, Bleeding Central
More informationBlood clotting. Subsequent covalent cross-linking of fibrin by a transglutaminase (factor XIII) further stabilizes the thrombus.
Blood clotting It is the conversion, catalyzed by thrombin, of the soluble plasma protein fibrinogen (factor I) into polymeric fibrin, which is deposited as a fibrous network in the primary thrombus. Thrombin
More informationMANAGEMENT OF COAGULOPATHY AFTER TRAUMA OR MAJOR SURGERY
MANAGEMENT OF COAGULOPATHY AFTER TRAUMA OR MAJOR SURGERY 19th ANNUAL CONTROVERSIES AND PROBLEMS IN SURGERY Thabo Mothabeng General Surgery: 1 Military Hospital HH Stone et al. Ann Surg. May 1983; 197(5):
More informationSeparation of Plasma and Serum and Their Proteins from Whole Blood
Separation of Plasma and Serum and Their Proteins from Whole Blood BCH 471 [Practical] BLOOD COMPOSITION Other names to blood cells Red blood cells (erythrocytes) White blood cells (leukocytes) Platelets
More informationM B Garvey. University of Toronto
Do I really need that test??? M B Garvey Professor Emeritus University of Toronto St Michael s Hospital No relevant conflicts of interest 1 HEMOSTASIS IS LIKE LOVE Everybody talks about it, nobody understands
More informationAppendix 3 PCC Warfarin Reversal
Appendix 3 PCC Warfarin Reversal Reversal of Warfarin and Analogues 1. Principle of Procedure Guidelines for the Reversal of Oral-anticoagulation in the Event of Life Threatening Haemorrhage Prothrombin
More informationClinical Profile of Envenomation in Children With Reference To Scorpion Sting
IOSR Journal of Dental and Medical Sciences (IOSR-JDMS) e-issn: 2279-853, p-issn: 2279-861.Volume 15, Issue 1 Ver. II (Jan. 16), PP 38-43 www.iosrjournals.org Clinical Profile of Envenomation in Children
More informationChapter 19. Hemostasis
Chapter 19 Hemostasis Hemostasis Hemostasis is the cessation of bleeding stopping potentially fatal leaks important in small blood vessels not effective in hemorrhage excessive bleeding from large blood
More informationCoagulation, Haemostasis and interpretation of Coagulation tests
Coagulation, Haemostasis and interpretation of Coagulation tests Learning Outcomes Indicate the normal ranges for routine clotting screen and explain what each measurement means Recognise how to detect
More informationStudy of correlation of changes in D-DIMER levels and coagulation profile with the development of coagulation disorders
Original article: Study of correlation of changes in D-DIMER levels and coagulation profile with the development of coagulation disorders 1 Dr Gurpreet Singh, 2 Dr Mahima Sharma, 3 Dr R K Chrungoo, 4 Dr.
More informationScorpion stings in children in the Asir Province of Saudi Arabia
Journalof Wilderness Medicine 4,241-251 (1993) ORIGINAL ARTICLE Scorpion stings in children in the Asir Province of Saudi Arabia S.H. ANNOBIL, MD, FRCP Departmentof Child Health, College of Medicine, King
More informationConsequences of Mesobuthus tamulus gangeticus (Pocock, 1900) envenomation in albino mice
The Journal of Venomous Animals and Toxins including Tropical Diseases ISSN 1678-9199 2010 volume 16 issue 3 pages 449-455 Original Paper Consequences of Mesobuthus tamulus gangeticus (Pocock, 1900) envenomation
More informationMANAGEMENT OF SEVERE SCORPION STING AT RURAL SETTINGS: WHAT IS THE ROLE OF SCORPION ANTIVENOM? BAWASKAR H. S. (1)
Received: May 3, 2004 Accepted: October 13, 2004 Published online: February 11, 2005. J. Venom. Anim. Toxins incl. Trop. Dis. V.11, n.1, p.3-7, 2005. Letter to the Editor - ISSN 1678-9199. MANAGEMENT OF
More informationGUIDELINES FOR THE EARLY MANAGEMENT OF PATIENTS WITH ACUTE ISCHEMIC STROKE
2018 UPDATE QUICK SHEET 2018 American Heart Association GUIDELINES FOR THE EARLY MANAGEMENT OF PATIENTS WITH ACUTE ISCHEMIC STROKE A Summary for Healthcare Professionals from the American Heart Association/American
More informationNEW ONE-STAGE PROCEDURES FOR THE QUANTITATIVE DETERMINATION OF PROTHROMBIN AND LABILE FACTOR*
NEW ONE-STAGE PROCEDURES FOR THE QUANTITATIVE DETERMINATION OF PROTHROMBIN AND LABILE FACTOR* MARIO STEFANINI, M.D.f From the Department ofbiochemistry, Marquette University School of Medicine, Milwaukee,
More informationHemodynamic Disorders, Thrombosis, and Shock. Richard A. McPherson, M.D.
Hemodynamic Disorders, Thrombosis, and Shock Richard A. McPherson, M.D. Edema The accumulation of abnormal amounts of fluid in intercellular spaces of body cavities. Inflammation and release of mediators
More informationA novel management method for disseminated intravascular coagulation like syndrome after a sting of Hemiscorpius lepturus: A case series
Tropical Biomedicine 28(3): 518 523 (2011) A novel management method for disseminated intravascular coagulation like syndrome after a sting of Hemiscorpius lepturus: A case series Ali A Shayesteh 1, Nima
More informationHEMOSTASIS Quality Time saving Economy Practicability Quality assurance Precision
Quality Time saving Economy Practicability Quality assurance Precision exclusive distributor of for France, Netherlands, Belgium and Luxembourg List of frozen reagents In 1992, Precision BioLogic began
More informationADMINISTRATIVE CLINICAL Page 1 of 6
ADMINISTRATIVE CLINICAL Page 1 of 6 Anticoagulant Guidelines #2: REVERSAL OF OR MANAGEMENT OF BLEEDING WITH ANTICOAGULANTS Origination Date: Revision Date: Reviewed Date: 09/12 09/12, 01/13, 11/13, 11/15
More informationThe Assay and Properties of Labile Factor (Factor V)
Marquette University e-publications@marquette Biomedical Sciences Faculty Research and Publications Health Sciences, College of -1-1960 The Assay and Properties of Labile Factor (Factor V) Armand J. Quick
More informationHemostatic derangement in Dengue infection
Hemostatic derangement in Dengue infection By Assoc. Prof. Darintr Sosothikul, MD Pediatric Hematology-Oncology division, King Chulalongkorn Memorial Hospital, Faculty of Medicine, Chulalongkorn University
More informationThe LaboratoryMatters
Laboratory Medicine Newsletter for clinicians, pathologists & clinical laboratory technologists. A Initiative. HEMOSTASIS AND THE LABORATORY This issue highlights: Primary Hemostasis Screening Tests Case
More informationHematology Review. CCRN exam. The Coagulation Cascade. The Coagulation Cascade. Components include: Intrinsic pathway Extrinsic pathway Common pathway
CCRN exam Hematology Review CCRN Review October 2013 Department of Critical Care Nursing Hematology is 2% of the exam Focus on coagulation cascade, DIC, and HIT Anatomy of the hematologic system Bone marrow
More informationBlood products and plasma substitutes
Blood products and plasma substitutes Plasma substitutes Dextran 70 and polygeline are macromolecular substances which are metabolized slowly; they may be used to expand and maintain blood volume in shock
More informationMajor Haemorrhage Protocol. Commentary
Hairmyres Hospital Monklands Hospital Wishaw General Hospital Major Haemorrhage Protocol Commentary N.B. There is a separate NHSL protocol for the Management of Obstetric Haemorrhage Authors Dr Tracey
More informationDiagnosis of hypercoagulability is by. Molecular markers
Agenda limitations of clinical laboratories to evaluate hypercoagulability and the underlying cause for thrombosis what is the INR the lupus anticoagulant and the antiphospholipid antibody syndrome hassouna
More informationIntroduction to coagulation and laboratory tests
Introduction to coagulation and laboratory tests Marc Jacquemin Special Haemostasis Laboratory Center for Molecular and Vascular Biology University of Leuven Coagulation in a blood vessel: fibrin stabilises
More informationBleeding and Haemostasis. Saman W.Boskani HDD, FIBMS Maxillofacial Surgeon
Bleeding and Haemostasis Saman W.Boskani HDD, FIBMS Maxillofacial Surgeon 1 Beeding Its escaping or extravasation of blood contents from blood vessels Types: - Arterial - Venous - Capillary Differences
More informationHemostasis Haemostasis means prevention of blood loss from blood vessels.
١ Hemostasis Haemostasis means prevention of blood loss from blood vessels. Bleeding is stopped by several mechanisms, which are: 1. Local vasoconstriction 2. Formation of platelet plug 3. Blood coagulation
More informationBlood coagulation and fibrinolysis. Blood clotting (HAP unit 5 th )
Blood coagulation and fibrinolysis Blood clotting (HAP unit 5 th ) Vessel injury Antithrombogenic (Favors fluid blood) Thrombogenic (Favors clotting) 3 Major systems involved Vessel wall Endothelium ECM
More informationAsian Pacific Journal of Tropical Disease
Asian Pac J Trop Dis 2015; 5(Suppl 1): S99-S103 S99 Contents lists available at ScienceDirect Asian Pacific Journal of Tropical Disease journal homepage: www.elsevier.com/locate/apjtd Original article
More informationInternational Journal of Pharma and Bio Sciences
Research Article Biochemistry International Journal of Pharma and Bio Sciences ISSN 0975-6299 COMPARISON OF PROTHROMBIN TIME AND ACTIVATED PARTIAL THROMBOPLASTIN TIME BETWEEN PATIENTS WITH DIABETES MELLITUS
More informationHematology Revision. By Dr.AboRashad . Mob
1 1- Hb A2 is consisting of: a) 3 ά chains and 2 γ chains b) 2 ά chains and 2 β chains c) 2 ά chains and 2 δ chains** d) 2 ά chains and 3 δ chains e) 3 ά chains and 2 δ chains 2- The main (most) Hb found
More informationMassive transfusion: Recent advances, guidelines & strategies. Dr.A.Surekha Devi Head, Dept. of Transfusion Medicine Global Hospital Hyderabad
Massive transfusion: Recent advances, guidelines & strategies Dr.A.Surekha Devi Head, Dept. of Transfusion Medicine Global Hospital Hyderabad Massive Hemorrhage Introduction Hemorrhage is a major cause
More informationBlood Lecture Test Questions Set 2 Summer 2012
Blood Lecture Test Questions Set 2 Summer 2012 1. Leukocytes are attracted to a site of injury or disease by: a. diapedesis b. chemotaxis c. leukocytosis d. heparin e. leukomotosis 2. Leukocytes leave
More informationCOMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE (CHMP) CORE SPC FOR HUMAN PROTHROMBIN COMPLEX PRODUCTS (CPMP/BPWG/3735/02)
European Medicines Agency Human Medicines Evaluation Unit London, 21 October 2004 Corrigendum, 18 November 2004 CPMP/BPWG/3735/02 COMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE (CHMP) CORE SPC FOR HUMAN
More informationActive date July Ratification date: Review date January 2014 Applies to: Staff managing patients on warfarin. Exclusions:
Guideline Title: Guidelines for the management of warfarin reversal [key words : Beriplex, Octaplex, PCC, vitamin K, anticoagulant, anticoagulation] Authors: Dr Sarah Allford, Consultant Haematologist
More informationShock, Hemorrhage and Thrombosis
Shock, Hemorrhage and Thrombosis 1 Shock Systemic hypoperfusion due to: Reduction in cardiac output Reduction in effective circulating blood volume Hypotension Impaired tissue perfusion Cellular hypoxia
More informationACQUIRED COAGULATION ABNORMALITIES
ACQUIRED COAGULATION ABNORMALITIES ACQUIRED COAGULATION ABNORMALITIES - causes 1. Liver disease 2. Vitamin K deficiency 3. Increased consumption of the clotting factors (disseminated intravascular coagulation
More informationPart IV Antithrombotics, Anticoagulants and Fibrinolytics
Part IV Antithrombotics, Anticoagulants and Fibrinolytics "The meaning of good and bad, of better and worse, is simply helping or hurting" Emerson Chapter 16: Blood Coagulation and Fibrinolytic System
More informationDIC. Bert Vandewiele Fellow Critical Care 23 May 2011
DIC Bert Vandewiele Fellow Critical Care 23 May 2011 Dissiminated Intravascular Coagulopathie 11/3/2011 Dr. Bert Vandewiele 2 Dissiminated Intravascular Coagulopathie = Consumption coagulopathie = Defibrination
More informationHemostasis. Learning objectives Dr. Mária Dux. Components: blood vessel wall thrombocytes (platelets) plasma proteins
Hemostasis Learning objectives 14-16 Dr. Mária Dux Components: blood vessel wall thrombocytes (platelets) plasma proteins Hemostatic balance! procoagulating activity anticoagulating activity 1 Thrombocytes
More informationTRAUMA RESUSCITATION. Dr. Carlos Palisi Dr. Nicholas Smith Liverpool Hospital
TRAUMA RESUSCITATION Dr. Carlos Palisi Dr. Nicholas Smith Liverpool Hospital First Principles.ATLS/EMST A- Airway and C-spine B- Breathing C- Circulation and Access D- Neurological deficit E- adequate
More informationNURSING DEPARTMENT CRITICAL CARE POLICY MANUAL CRITICAL CARE PROTOCOLS. ACUTE CEREBROVASCULAR ACCIDENT TPA (ACTIVASE /alteplase) FOR THROMBOLYSIS
NURSING DEPARTMENT CRITICAL CARE POLICY MANUAL CRITICAL CARE PROTOCOLS ACUTE CEREBROVASCULAR ACCIDENT TPA (ACTIVASE /alteplase) FOR THROMBOLYSIS I. Purpose : A. To reduce morbidity and mortality associated
More informationFull Article Antivenom injection time related effects of Hemiscorpius lepturus scorpion envenomation in rabbits
Archives of Razi Institute, Vol. 66, No. 2, December (2011) 139-145 Copyright 2011 by Razi Vaccine & Serum Research Institute Full Article Antivenom time related effects of Hemiscorpius lepturus scorpion
More informationINTRODUCTION Death due to severe scorpion envenoming syndrome. VS Natu*, RKK Murthy**, KP Deodhar*** Abstract. Original Article
Original Article Efficacy of Species Specific Anti-scorpion Venom Serum (AScVS) against Severe, Serious Scorpion Stings (Mesobuthus tamulus concanesis Pocock) An Experience from Rural Hospital in Western
More informationFELINE HEMATOLOGY Inherited and Acquired Bleeding Disorders Marjory Brooks DVM, D.ACVIM
FELINE HEMATOLOGY Marjorie Brooks, D.V.M. Diplomate, A.C.V.I.M. Comparative Hematology Laboratory N.Y.S. Department of Health WCL&R P. O. Box 509 Albany, NY 12201 f / b - f / i 3 FELINE HEMATOLOGY Inherited
More informationEffective Date: Approved by: Laboratory Director, Jerry Barker (electronic signature)
1 of 5 Policy #: 702 (PHL-702-05) Effective Date: 9/30/2004 Reviewed Date: 8/1/2016 Subject: TRANSFUSION GUIDELINES Approved by: Laboratory Director, Jerry Barker (electronic signature) Approved by: Laboratory
More informationPrimary Exam Physiology lecture 5. Haemostasis
Primary Exam Physiology lecture 5 Haemostasis Haemostasis Body s response for the prevention and cessation of bleeding. Broadly consists of: Primary Haemostasis - vascular spasm and platlet plug formation
More informationAutonomic dysfunctions in patients with scorpion sting: early predictors of severe disease
International Journal of Advances in Medicine Kumaraswamy RCG et al. Int J Adv Med. 2014 Nov;1(3):241-246 http://www.ijmedicine.com pissn 2349-3925 eissn 2349-3933 Research Article DOI: 10.5455/2349-3933.ijam20141118
More informationStep 2. Common Blood Tests, and the Coulter Counter Readout
Step 2. Common Blood Tests, and the Coulter Counter Readout We will be learning about some common blood tests. We will not be preforming most of them in lab. The student should know their names, their
More informationProceedings of the World Small Animal Veterinary Association Sydney, Australia 2007
Proceedings of the World Small Animal Veterinary Association Sydney, Australia 2007 Hosted by: Australian Small Animal Veterinary Association (ASAVA) Australian Small Animal Veterinary Association (ASAVA)
More informationCoagulation an Overview Dr.Abdolreza Abdolr Afrasiabi Thal assem a & Heamophili hilia G ene i tic R esearc C en er Shiraz Medical Medic University
In The Name God Coagulation an Overview Dr.Abdolreza Afrasiabi Thalassemia & Heamophilia Genetic Research hcenter Shiraz Medical University Bleeding Clotting Hemostasis Review of platelet function Platelets
More informationApproach to bleeding disorders &treatment. by RAJESH.N General medicine post graduate
Approach to bleeding disorders &treatment by RAJESH.N General medicine post graduate 2 Approach to a patient of bleeding diathesis 1. Clinical evaluation: History, Clinical features 2. Laboratory approach:
More informationVehicle ACT. 180 min. Time After Current Initiation (min) 180 min. Vehicle. UFH (75 U/kg) Anti-Factor Xa. Time After Current Initiation (min)
Efficacy of, a Rationally-Engineered Low-Molecular-Weight Heparin, in a Canine Model of Arterial Thrombosis Ian D Fier, Mark A Nedelman, J Luis Guerrero, Ganesh Venkataraman, and Yi Wei Qi Momenta Pharmaceuticals,
More informationUnrestricted. Dr ppooransari fellowship of perenatalogy
Unrestricted Dr ppooransari fellowship of perenatalogy Assessment of severity of hemorrhage Significant drops in blood pressure are generally not manifested until substantial bleeding has occurred, and
More informationUpdated Ischemic Stroke Guidelines นพ.ส ชาต หาญไชยพ บ ลย ก ล นายแพทย ทรงค ณว ฒ สาขาประสาทว ทยา สถาบ นประสาทว ทยา กรมการแพทย กระทรวงสาธารณส ข
Updated Ischemic Stroke Guidelines นพ.ส ชาต หาญไชยพ บ ลย ก ล นายแพทย ทรงค ณว ฒ สาขาประสาทว ทยา สถาบ นประสาทว ทยา กรมการแพทย กระทรวงสาธารณส ข Emergency start at community level: Prehospital care Acute stroke
More informationEvaluating Some Medical Lab Parameters among Hospitalized Children In Khuzestan Following Scorpion Sting, SW Iran
Original Article Print ISSN: 2321-6379 Online ISSN: 2321-595X DOI: 10.17354/ijssJuneI/2017/014 Evaluating Some Medical Lab Parameters among Hospitalized Children In Khuzestan Following Sting, SW Iran Babak
More informationAgent Dose MoA/PK/Admin Adverse events Disadvantages Protamine Heparin: 1mg neutralizes ~ 100 units Heparin neutralization in ~ 5 min
Nanik (Nayri) Hatsakorzian Pharm.D/MPH candidate 2014 Touro University College of Pharmacy CA Bleeding Reversal Agents Agent Dose MoA/PK/Admin Adverse events Disadvantages Protamine Heparin: 1mg neutralizes
More informationOriginal Article Spatial Distribution of Medically Important Scorpions in North West of Iran
Original Article Spatial Distribution of Medically Important Scorpions in North West of Iran Mulood Mohammadi Bavani 1, *Javad Rafinejad 1, *Ahmad Ali Hanafi-Bojd 1, Mohammad Ali Oshaghi 1, Shahrokh Navidpour
More informationHemostasis Haemostasis means prevention of blood loss from blood vessels.
1 Hemostasis Haemostasis means prevention of blood loss from blood vessels. Bleeding is stopped by several mechanisms, which are: 1. Local vasoconstriction 2. Formation of platelet plug 3. Blood coagulation
More informationApproach To A Bleeding Patient
ABDUL MAJEED, RAHUL RAJEEV REVIEW ARTICLE INTRODUCTION Hemostasis is the process of forming clots in the walls of damaged blood vessels and preventing blood loss while maintaining blood in a fluid state
More informationManaging Coagulopathy in Intensive Care Setting
Managing Coagulopathy in Intensive Care Setting Dr Rock LEUNG Associate Consultant Division of Haematology, Department of Pathology & Clinical Biochemistry Queen Mary Hospital Normal Haemostasis Primary
More informationPrincess Alexandra Hospital Emergency Department. Clinical Module. Clinical features of envenoming: Major toxin syndromes 1 :
Princess Alexandra Hospital Emergency Department Clinical Module Toxicology Review Officer: Toxicology registrar Version no: 1 Approval date: February 2017 Review date: February 2019 Approving Officer
More informationTHE fundamental concepts of blood coagulation formulated almost 50 years
NEWER CONCEPTS OF BLOOD COAGULATION ARTHUR L. SCHERBEL, M.D., M.S. in Medicine Department of Medicine THE fundamental concepts of blood coagulation formulated almost 50 years ago by Morawitz 1 have not
More informationPICT ANTICOAGULANT MONITORING 1. PEFAKIT PICT. Clotting Assay. PEFAKIT PiCT. PEFAKIT PICT Calibrators UFH. PEFAKIT PICT Controls UFH
1 2 3 4 PEFAKIT PiCT PEFAKIT PICT Calibrators UFH PEFAKIT PICT Controls UFH PEFAKIT PICT Calibrators LMWH Clotting Assay PICT 1. PEFAKIT PICT Package size 8-505-01 kit 80 3 vials of PiCT Activator (2mL)
More informationGuidance for management of bleeding in patients taking the new oral anticoagulant drugs: rivaroxaban, dabigatran or apixaban
Guidance for management of bleeding in patients taking the new oral anticoagulant drugs: rivaroxaban, dabigatran or apixaban Purpose The aim of this guidance is to outline the management of patients presenting
More informationCASE REPORT RENAL FAILURE AND DIC-LIKE SYNDROME FOLLOWING SNAKE BITES
CASE REPORT RENAL FAILURE AND DIC-LIKE SYNDROME FOLLOWING SNAKE BITES Fransciscus Ginting, Restuti, Endang, Tambar Kembaren, Yosia Ginting, Ricky Rivalino Sitepu Tropical Infenction Medicine - Internal
More informationHematology. The Study of blood
Hematology The Study of blood Average adult = 8-10 pints of blood Composition: PLASMA liquid portion of blood without cellular components Serum plasma after a blood clot is formed Cellular elements are
More informationMohammadreza Tabatabaei IBTO COAG LAB
Tests for the Evaluation of Lupus Anticoagulants t Mohammadreza Tabatabaei MSc Hematology blood bank MSc Hematology blood bank IBTO COAG LAB Lupus Anticoagulants General Background Lupus anticoagulants
More informationTransfusion Requirements and Management in Trauma RACHEL JACK
Transfusion Requirements and Management in Trauma RACHEL JACK Overview Haemostatic resuscitation Massive Transfusion Protocol Overview of NBA research guidelines Haemostatic resuscitation Permissive hypotension
More informationHemostasis. Clo)ng factors and Coagula4on NORMAL COAGULATION. Overview of blood coagula4on. The Cascade Theory 5/1/12. Clot
Hemostasis Clo)ng factors and Coagula4on Dr Badri Paudel www.badripaudel.com Hemostasis is defined as a property of circula4on whereby blood is maintained within a vessel and the ability of the system
More informationBlood. Water compartments
Blood Water compartments 2/8 about 60% of our body is water (young-old, male-female) water is located in compartments, movement is regulated intracellular : extracellular 2:1, i.e. 40:20% interstitial
More information